{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,15]],"date-time":"2026-02-15T21:09:06Z","timestamp":1771189746706,"version":"3.50.1"},"reference-count":97,"publisher":"The Endocrine Society","issue":"12","license":[{"start":{"date-parts":[[2025,11,20]],"date-time":"2025-11-20T00:00:00Z","timestamp":1763596800000},"content-version":"vor","delay-in-days":14,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,11,6]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Context<\/jats:title>\n                    <jats:p>Women with polycystic ovary syndrome (PCOS) and PCOS animal models have diminished brown adipose tissue (BAT) activity, potentially contributing to metabolic dysfunction. Besides classical androgens, adrenal 11-oxygenated androgens are elevated in women with PCOS. However, it remains unknown whether these 11-oxygenated androgens affect BAT metabolism.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>To study the effects of 11-ketotestosterone (KT) and 11-ketodihydrotestosterone (KDHT) on BAT metabolism.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>The female mouse brown adipocyte cell line T37i was treated with increasing concentrations (0.1-10\u2005\u00b5M) of testosterone (T), dihydrotestosterone (DHT), KT, or KDHT during or after differentiation. In addition, female mice received a daily injection of vehicle, DHT, KT, or KDHT (100\u2005\u00b5g) for 1 day or 1 week. Adipose depots were collected for RNA sequencing (RNAseq) analysis and Gene Set Enrichment Analysis (GSEA).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>During differentiation, T, KT, DHT, and KDHT treatment of T37i cells dose-dependently reduced lipid droplet accumulation, and downregulated mRNA expression of adipogenic markers by up to 50%, with KDHT having the weakest effect. In mature T37i cells, only the high concentrations of these androgens exhibited inhibitory effects. RNAseq analysis revealed that DHT exposure induced the most differentially regulated genes in BAT, followed by KT and KDHT treatment. GSEA indicated that 1-day treatment with DHT and KT, but not KDHT, resulted in the downregulation of metabolic pathways in BAT.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>11-Oxygenated androgens at high concentrations directly inhibit brown adipocyte differentiation in vitro and KT acutely downregulates BAT metabolic transcriptome in vivo, a result not observed with KDHT. These findings suggest that elevated 11-oxygenated androgens may impair BAT function, contributing to metabolic complications associated with hyperandrogenic conditions, including PCOS.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1210\/endocr\/bqaf172","type":"journal-article","created":{"date-parts":[[2025,11,17]],"date-time":"2025-11-17T12:25:42Z","timestamp":1763382342000},"source":"Crossref","is-referenced-by-count":2,"title":["<scp>11-<\/scp>\n                    Oxygenated Androgens Inhibit Brown Adipose Tissue Differentiation"],"prefix":"10.1210","volume":"166","author":[{"given":"Yini","family":"Yuan","sequence":"first","affiliation":[{"name":"Department of Internal Medicine, Erasmus MC, University Medical Center Rotterdam , Rotterdam, 3000 CA ,","place":["the Netherlands"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jacobie","family":"Steenbergen","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Erasmus MC, University Medical Center Rotterdam , Rotterdam, 3000 CA ,","place":["the Netherlands"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Afonso","family":"de Oliveira Santos Goulart","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Erasmus MC, University Medical Center Rotterdam , Rotterdam, 3000 CA ,","place":["the Netherlands"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8257-6406","authenticated-orcid":false,"given":"Alba","family":"Sabat\u00e9-P\u00e9rez","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Erasmus MC, University Medical Center Rotterdam , Rotterdam, 3000 CA ,","place":["the Netherlands"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7182-3571","authenticated-orcid":false,"given":"Jenny A","family":"Visser","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Erasmus MC, University Medical Center Rotterdam , Rotterdam, 3000 CA ,","place":["the Netherlands"]}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"80","published-online":{"date-parts":[[2025,11,19]]},"reference":[{"issue":"9","key":"2025112703415161500_bqaf172-B1","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1016\/S2213-8587(22)00163-2","article-title":"Polycystic ovary syndrome","volume":"10","author":"Joham","year":"2022","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"4","key":"2025112703415161500_bqaf172-B2","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1038\/nrendo.2010.217","article-title":"Polycystic ovary syndrome: etiology, pathogenesis and diagnosis","volume":"7","author":"Goodarzi","year":"2011","journal-title":"Nat Rev Endocrinol"},{"issue":"4","key":"2025112703415161500_bqaf172-B3","doi-asserted-by":"crossref","first-page":"1454","DOI":"10.3390\/jcm12041454","article-title":"Polycystic ovary syndrome: etiology, current management, and future therapeutics","volume":"12","author":"Singh","year":"2023","journal-title":"J Clin Med"},{"key":"2025112703415161500_bqaf172-B4","doi-asserted-by":"crossref","first-page":"100937","DOI":"10.1016\/j.molmet.2020.01.001","article-title":"Metabolic dysfunction in polycystic ovary syndrome: pathogenic role of androgen excess and potential therapeutic strategies","volume":"35","author":"Sanchez-Garrido","year":"2020","journal-title":"Mol Metab"},{"issue":"3","key":"2025112703415161500_bqaf172-B5","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1093\/humupd\/dmt061","article-title":"Definition and significance of polycystic ovarian morphology: a task force report from the androgen excess and polycystic ovary syndrome society","volume":"20","author":"Dewailly","year":"2014","journal-title":"Hum Reprod Update"},{"issue":"1","key":"2025112703415161500_bqaf172-B6","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.fertnstert.2003.10.004","article-title":"Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome","volume":"81","author":"Rotterdam ESHRE\/ASRM-Sponsored PCOS Consensus Workshop Group","year":"2004","journal-title":"Fertil Steril"},{"key":"2025112703415161500_bqaf172-B7","doi-asserted-by":"crossref","first-page":"1273542","DOI":"10.3389\/fendo.2023.1273542","article-title":"Androgen excess: a hallmark of polycystic ovary syndrome","volume":"14","author":"Wang","year":"2023","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"9","key":"2025112703415161500_bqaf172-B8","doi-asserted-by":"crossref","first-page":"4522","DOI":"10.1210\/en.2012-1283","article-title":"Prenatal exposure to low levels of androgen accelerates female puberty onset and reproductive senescence in mice","volume":"153","author":"Witham","year":"2012","journal-title":"Endocrinology"},{"issue":"3","key":"2025112703415161500_bqaf172-B9","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1507\/endocrj.K09E-205","article-title":"Endocrine traits of polycystic ovary syndrome in prenatally androgenized female Sprague-Dawley rats","volume":"57","author":"Wu","year":"2010","journal-title":"Endocr J"},{"issue":"3","key":"2025112703415161500_bqaf172-B10","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1095\/biolreprod61.3.599","article-title":"Prenatal testosterone masculinizes synaptic input to gonadotropin-releasing hormone neurons in sheep","volume":"61","author":"Kim","year":"1999","journal-title":"Biol Reprod"},{"issue":"5","key":"2025112703415161500_bqaf172-B11","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1038\/nrendo.2018.24","article-title":"Polycystic ovary syndrome: definition, aetiology, diagnosis and treatment","volume":"14","author":"Escobar-Morreale","year":"2018","journal-title":"Nat Rev Endocrinol"},{"key":"2025112703415161500_bqaf172-B12","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1016\/j.cca.2019.11.003","article-title":"Polycystic ovarian syndrome: correlation between hyperandrogenism, insulin resistance and obesity","volume":"502","author":"Zeng","year":"2020","journal-title":"Clin Chim Acta"},{"issue":"6","key":"2025112703415161500_bqaf172-B13","doi-asserted-by":"crossref","first-page":"2861","DOI":"10.1210\/en.2011-1754","article-title":"Reproductive and metabolic phenotype of a mouse model of PCOS","volume":"153","author":"van Houten","year":"2012","journal-title":"Endocrinology"},{"issue":"4","key":"2025112703415161500_bqaf172-B14","doi-asserted-by":"crossref","first-page":"bnaa010","DOI":"10.1210\/endrev\/bnaa010","article-title":"Animal models to understand the etiology and pathophysiology of polycystic ovary syndrome","volume":"41","author":"Stener-Victorin","year":"2020","journal-title":"Endocr Rev"},{"issue":"2","key":"2025112703415161500_bqaf172-B15","doi-asserted-by":"crossref","first-page":"E145","DOI":"10.1152\/ajpendo.00418.2021","article-title":"Androgen signaling in adipose tissue, but less likely skeletal muscle, mediates development of metabolic traits in a PCOS mouse model","volume":"323","author":"Xiong","year":"2022","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"2025112703415161500_bqaf172-B16","doi-asserted-by":"crossref","first-page":"116012","DOI":"10.1016\/j.bcp.2023.116012","article-title":"White-brown adipose tissue interplay in polycystic ovary syndrome: therapeutic avenues","volume":"220","author":"Abbasi","year":"2024","journal-title":"Biochem Pharmacol"},{"issue":"1","key":"2025112703415161500_bqaf172-B17","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1210\/clinem\/dgad356","article-title":"Adipose tissue dysfunction in polycystic ovary syndrome","volume":"109","author":"Bril","year":"2023","journal-title":"J Clin Endocrinol Metab"},{"issue":"4","key":"2025112703415161500_bqaf172-B18","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1038\/s41580-018-0093-z","article-title":"Adipogenesis and metabolic health","volume":"20","author":"Ghaben","year":"2019","journal-title":"Nat Rev Mol Cell Biol"},{"issue":"6","key":"2025112703415161500_bqaf172-B19","doi-asserted-by":"crossref","first-page":"1537","DOI":"10.2337\/db06-0263","article-title":"Adipose tissue: from lipid storage compartment to endocrine organ","volume":"55","author":"Scherer","year":"2006","journal-title":"Diabetes"},{"issue":"1","key":"2025112703415161500_bqaf172-B20","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1152\/physrev.00015.2003","article-title":"Brown adipose tissue: function and physiological significance","volume":"84","author":"Cannon","year":"2004","journal-title":"Physiol Rev"},{"issue":"7503","key":"2025112703415161500_bqaf172-B21","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1038\/nature13477","article-title":"The different shades of fat","volume":"510","author":"Peirce","year":"2014","journal-title":"Nature"},{"issue":"11","key":"2025112703415161500_bqaf172-B22","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1038\/nrm.2016.96","article-title":"Control of brown and beige fat development","volume":"17","author":"Wang","year":"2016","journal-title":"Nat Rev Mol Cell Biol"},{"issue":"8","key":"2025112703415161500_bqaf172-B23","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1038\/nrm.2016.62","article-title":"Transcriptional and epigenetic control of brown and beige adipose cell fate and function","volume":"17","author":"Inagaki","year":"2016","journal-title":"Nat Rev Mol Cell Biol"},{"issue":"5","key":"2025112703415161500_bqaf172-B24","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1530\/EJE-19-0505","article-title":"Brown adipose tissue activity is reduced in women with polycystic ovary syndrome","volume":"181","author":"Oliveira","year":"2019","journal-title":"Eur J Endocrinol"},{"key":"2025112703415161500_bqaf172-B25","doi-asserted-by":"crossref","first-page":"108777","DOI":"10.1016\/j.ejrad.2019.108777","article-title":"Characterization of brown adipose tissue (BAT) in polycystic ovary syndrome (PCOS) patients by Z-spectral imaging (ZSI)","volume":"123","author":"Li","year":"2020","journal-title":"Eur J Radiol"},{"issue":"3","key":"2025112703415161500_bqaf172-B26","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1111\/cen.13913","article-title":"Brown adipose tissue thermogenesis in polycystic ovary syndrome","volume":"90","author":"Shorakae","year":"2019","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"34","key":"2025112703415161500_bqaf172-B27","doi-asserted-by":"crossref","first-page":"E7187","DOI":"10.1073\/pnas.1708854114","article-title":"Adiponectin protects against development of metabolic disturbances in a PCOS mouse model","volume":"114","author":"Benrick","year":"2017","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"10","key":"2025112703415161500_bqaf172-B28","doi-asserted-by":"crossref","first-page":"2708","DOI":"10.1073\/pnas.1523236113","article-title":"Brown adipose tissue transplantation ameliorates polycystic ovary syndrome","volume":"113","author":"Yuan","year":"2016","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2025112703415161500_bqaf172-B29","doi-asserted-by":"crossref","first-page":"747944","DOI":"10.3389\/fendo.2021.747944","article-title":"Brown adipose transplantation improves polycystic ovary syndrome-involved metabolome remodeling","volume":"12","author":"Yao","year":"2021","journal-title":"Front Endocrinol (Lausanne)"},{"key":"2025112703415161500_bqaf172-B30","doi-asserted-by":"crossref","first-page":"744628","DOI":"10.3389\/fendo.2021.744628","article-title":"Brown adipose tissue activation by cold treatment ameliorates polycystic ovary syndrome in rat","volume":"12","author":"Ye","year":"2021","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"10","key":"2025112703415161500_bqaf172-B31","doi-asserted-by":"crossref","first-page":"1714","DOI":"10.1007\/PL00012499","article-title":"Opposite actions of testosterone and progesterone on UCP1 mRNA expression in cultured brown adipocytes","volume":"59","author":"Rodriguez","year":"2002","journal-title":"Cell Mol Life Sci"},{"issue":"1","key":"2025112703415161500_bqaf172-B32","doi-asserted-by":"crossref","first-page":"E340","DOI":"10.1152\/ajpendo.00175.2006","article-title":"Expression of mitochondrial biogenesis-signaling factors in brown adipocytes is influenced specifically by 17beta-estradiol, testosterone, and progesterone","volume":"292","author":"Rodriguez-Cuenca","year":"2007","journal-title":"Am J Physiol Endocrinol Metab"},{"issue":"1","key":"2025112703415161500_bqaf172-B33","doi-asserted-by":"crossref","first-page":"243","DOI":"10.3390\/ijms22010243","article-title":"Androgen reduces mitochondrial respiration in mouse brown adipocytes: a model for disordered energy balance in polycystic ovary syndrome","volume":"22","author":"Lerner","year":"2020","journal-title":"Int J Mol Sci"},{"issue":"2","key":"2025112703415161500_bqaf172-B34","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/S0889-8529(05)70070-0","article-title":"Ovarian and adrenal function in polycystic ovary syndrome","volume":"28","author":"Rosenfield","year":"1999","journal-title":"Endocrinol Metab Clin North Am"},{"issue":"4","key":"2025112703415161500_bqaf172-B35","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1007\/s11154-007-9054-0","article-title":"The adrenal and polycystic ovary syndrome","volume":"8","author":"Yildiz","year":"2007","journal-title":"Rev Endocr Metab Disord"},{"issue":"1","key":"2025112703415161500_bqaf172-B36","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/S0015-0282(16)55152-8","article-title":"The ratio of androstenedione:11 beta-hydroxyandrostenedione is an important marker of adrenal androgen excess in women","volume":"58","author":"Carmina","year":"1992","journal-title":"Fertil Steril"},{"issue":"5","key":"2025112703415161500_bqaf172-B37","doi-asserted-by":"crossref","first-page":"e2047","DOI":"10.1210\/clinem\/dgab920","article-title":"Clinical value of serum levels of 11-oxygenated metabolites of testosterone in women with polycystic ovary syndrome","volume":"107","author":"Tosi","year":"2022","journal-title":"J Clin Endocrinol Metab"},{"issue":"3","key":"2025112703415161500_bqaf172-B38","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1210\/jc.2016-3285","article-title":"11-Oxygenated c19 steroids are the predominant androgens in polycystic ovary syndrome","volume":"102","author":"O'Reilly","year":"2017","journal-title":"J Clin Endocrinol Metab"},{"key":"2025112703415161500_bqaf172-B39","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1016\/j.jsbmb.2019.04.005","article-title":"Circulating 11-oxygenated androgens across species","volume":"190","author":"Rege","year":"2019","journal-title":"J Steroid Biochem Mol Biol"},{"issue":"6","key":"2025112703415161500_bqaf172-B40","doi-asserted-by":"crossref","first-page":"C5","DOI":"10.1530\/EJE-22-0820","article-title":"A commentary on the origins of 11-ketotestosterone","volume":"187","author":"Storbeck","year":"2022","journal-title":"Eur J Endocrinol"},{"issue":"5","key":"2025112703415161500_bqaf172-B41","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1210\/jcem-62-5-840","article-title":"Adrenal androgen hyperresponsiveness to adrenocorticotropin in women with acne and\/or hirsutism: adrenal enzyme defects and exaggerated adrenarche","volume":"62","author":"Lucky","year":"1986","journal-title":"J Clin Endocrinol Metab"},{"issue":"7","key":"2025112703415161500_bqaf172-B42","first-page":"2317","article-title":"Adrenal androgen excess in the polycystic ovary syndrome: sensitivity and responsivity of the hypothalamic-pituitary-adrenal axis","volume":"83","author":"Azziz","year":"1998","journal-title":"J Clin Endocrinol Metab"},{"issue":"9","key":"2025112703415161500_bqaf172-B43","doi-asserted-by":"crossref","first-page":"2626","DOI":"10.1210\/clinem\/dgac365","article-title":"Excess 11-oxygenated androgens in women with severe insulin resistance are mediated by adrenal insulin receptor signaling","volume":"107","author":"Walzer","year":"2022","journal-title":"J Clin Endocrinol Metab"},{"issue":"Suppl 1","key":"2025112703415161500_bqaf172-B44","doi-asserted-by":"crossref","first-page":"S16","DOI":"10.1016\/S0140-6736(15)60331-2","article-title":"Effect of insulin on AKR1C3 expression in female adipose tissue: in-vivo and in-vitro study of adipose androgen generation in polycystic ovary syndrome","volume":"385","author":"O'Reilly","year":"2015","journal-title":"Lancet"},{"issue":"17","key":"2025112703415161500_bqaf172-B45","doi-asserted-by":"crossref","first-page":"9691","DOI":"10.3390\/ijms25179691","article-title":"The role of 11-oxygenated androgens and endocrine disruptors in androgen excess disorders in women","volume":"25","author":"Vitku","year":"2024","journal-title":"Int J Mol Sci"},{"issue":"1","key":"2025112703415161500_bqaf172-B46","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1093\/ejendo\/lvac017","article-title":"Classic and 11-oxygenated androgens in serum and saliva across adulthood: a cross-sectional study analyzing the impact of age, body mass index, and diurnal and menstrual cycle variation","volume":"188","author":"Schiffer","year":"2023","journal-title":"Eur J Endocrinol"},{"issue":"10","key":"2025112703415161500_bqaf172-B47","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1507\/endocrj.EJ18-0212","article-title":"11-oxygenated C19 steroids as circulating androgens in women with polycystic ovary syndrome","volume":"65","author":"Yoshida","year":"2018","journal-title":"Endocr J"},{"issue":"10","key":"2025112703415161500_bqaf172-B48","doi-asserted-by":"crossref","first-page":"2367","DOI":"10.1210\/en.2019-00194","article-title":"Sex difference in corticosterone-induced insulin resistance in mice","volume":"160","author":"Kaikaew","year":"2019","journal-title":"Endocrinology"},{"issue":"2","key":"2025112703415161500_bqaf172-B49","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1530\/JME-20-0210","article-title":"Sex difference in the mouse BAT transcriptome reveals a role of progesterone","volume":"66","author":"Kaikaew","year":"2021","journal-title":"J Mol Endocrinol"},{"issue":"1","key":"2025112703415161500_bqaf172-B50","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/S1570-0232(03)00371-4","article-title":"MitoTracker green labeling of mitochondrial proteins and their subsequent analysis by capillary electrophoresis with laser-induced fluorescence detection","volume":"793","author":"Presley","year":"2003","journal-title":"J Chromatogr B Analyt Technol Biomed Life Sci"},{"issue":"1","key":"2025112703415161500_bqaf172-B51","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1186\/s13293-015-0025-y","article-title":"Estrogens increase expression of bone morphogenetic protein 8b in brown adipose tissue of mice","volume":"6","author":"Grefhorst","year":"2015","journal-title":"Biol Sex Differ"},{"issue":"1","key":"2025112703415161500_bqaf172-B52","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1111\/j.0022-202X.2004.23545.x","article-title":"Gender differences in mouse skin morphology and specific effects of sex steroids and dehydroepiandrosterone","volume":"124","author":"Azzi","year":"2005","journal-title":"J Invest Dermatol"},{"issue":"3","key":"2025112703415161500_bqaf172-B53","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1002\/mrd.20949","article-title":"Fine temporal analysis of DHT transcriptional modulation of the ATM\/Gadd45g signaling pathways in the mouse uterus","volume":"76","author":"Ivanga","year":"2009","journal-title":"Mol Reprod Dev"},{"issue":"2","key":"2025112703415161500_bqaf172-B54","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1677\/jme.1.01503","article-title":"Effects of dihydrotestosterone on adipose tissue measured by serial analysis of gene expression","volume":"33","author":"Bolduc","year":"2004","journal-title":"J Mol Endocrinol"},{"issue":"1","key":"2025112703415161500_bqaf172-B55","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1038\/nprot.2008.211","article-title":"Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources","volume":"4","author":"Huang da","year":"2009","journal-title":"Nat Protoc"},{"issue":"8","key":"2025112703415161500_bqaf172-B56","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1002\/cbf.3366","article-title":"Role of estradiol and testosterone in Ucp1 expression in brown\/beige adipocytes","volume":"36","author":"Suzuki","year":"2018","journal-title":"Cell Biochem Funct"},{"key":"2025112703415161500_bqaf172-B57","doi-asserted-by":"crossref","unstructured":"Yuan Y, Steenbergen J, de Oliveira Santos Goulart A, Sabat\u00e9-P\u00e9rez A, Visser JA. \u00a0Supplementary material for \u201c11-Oxygenated Androgens Inhibit Brown Adipose Tissue Differentiation\u201d. Figshare. 2025. 10.6084\/m9.figshare.28429505.v1","DOI":"10.1210\/endocr\/bqaf172"},{"key":"2025112703415161500_bqaf172-B58","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1007\/164_2018_168","article-title":"Brown adipose tissue development and metabolism","volume":"251","author":"Jung","year":"2019","journal-title":"Handb Exp Pharmacol"},{"issue":"2","key":"2025112703415161500_bqaf172-B59","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1016\/j.ando.2022.11.004","article-title":"Polycystic ovary syndrome and adipose tissue","volume":"84","author":"Lemaitre","year":"2023","journal-title":"Ann Endocrinol (Paris)"},{"key":"2025112703415161500_bqaf172-B60","doi-asserted-by":"crossref","first-page":"1065263","DOI":"10.3389\/fendo.2022.1065263","article-title":"An update on brown adipose tissue and obesity intervention: function, regulation and therapeutic implications","volume":"13","author":"Liu","year":"2023","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"3","key":"2025112703415161500_bqaf172-B61","doi-asserted-by":"crossref","first-page":"927","DOI":"10.2353\/ajpath.2009.081155","article-title":"Mitochondrial (dys)function in adipocyte (de)differentiation and systemic metabolic alterations","volume":"175","author":"De Pauw","year":"2009","journal-title":"Am J Pathol"},{"issue":"3","key":"2025112703415161500_bqaf172-B62","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1128\/MCB.23.3.1085-1094.2003","article-title":"Mitochondrial biogenesis and remodeling during adipogenesis and in response to the insulin sensitizer rosiglitazone","volume":"23","author":"Wilson-Fritch","year":"2003","journal-title":"Mol Cell Biol"},{"key":"2025112703415161500_bqaf172-B63","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1042\/bse0470069","article-title":"Regulation of mitochondrial biogenesis","volume":"47","author":"Jornayvaz","year":"2010","journal-title":"Essays Biochem"},{"issue":"9","key":"2025112703415161500_bqaf172-B64","doi-asserted-by":"crossref","first-page":"4892","DOI":"10.1111\/jcmm.15194","article-title":"Mitochondrial biogenesis: an update","volume":"24","author":"Popov","year":"2020","journal-title":"J Cell Mol Med"},{"issue":"11","key":"2025112703415161500_bqaf172-B65","doi-asserted-by":"crossref","first-page":"1855","DOI":"10.1373\/clinchem.2008.103846","article-title":"Simultaneous measurement of serum testosterone and dihydrotestosterone by liquid chromatography-tandem mass spectrometry","volume":"54","author":"Shiraishi","year":"2008","journal-title":"Clin Chem"},{"key":"2025112703415161500_bqaf172-B66","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1016\/j.jpba.2018.11.035","article-title":"Simultaneous analysis by LC-MS\/MS of 22 ketosteroids with hydroxylamine derivatization and underivatized estradiol from human plasma, serum and prostate tissue","volume":"164","author":"Hakkinen","year":"2019","journal-title":"J Pharm Biomed Anal"},{"issue":"7","key":"2025112703415161500_bqaf172-B67","doi-asserted-by":"crossref","first-page":"2615","DOI":"10.1210\/jc.2018-02527","article-title":"11-Oxygenated C19 steroids do not decline with age in women","volume":"104","author":"Nanba","year":"2019","journal-title":"J Clin Endocrinol Metab"},{"issue":"5","key":"2025112703415161500_bqaf172-B68","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1038\/s41574-020-0336-x","article-title":"11-Oxygenated androgens in health and disease","volume":"16","author":"Turcu","year":"2020","journal-title":"Nat Rev Endocrinol"},{"issue":"1","key":"2025112703415161500_bqaf172-B69","doi-asserted-by":"crossref","first-page":"13","DOI":"10.3121\/cmr.2.1.13","article-title":"Polycystic ovarian syndrome: diagnosis and management","volume":"2","author":"Sheehan","year":"2004","journal-title":"Clin Med Res"},{"issue":"1","key":"2025112703415161500_bqaf172-B70","doi-asserted-by":"crossref","first-page":"bqad175","DOI":"10.1210\/endocr\/bqad175","article-title":"A novel tissue-specific insight into sex steroid fluctuations throughout the murine estrous cycle","volume":"165","author":"Unger","year":"2023","journal-title":"Endocrinology"},{"issue":"6","key":"2025112703415161500_bqaf172-B71","doi-asserted-by":"crossref","first-page":"1869","DOI":"10.1096\/fj.08-119388","article-title":"Sex of the cell dictates its response: differential gene expression and sensitivity to cell death inducing stress in male and female cells","volume":"23","author":"Penaloza","year":"2009","journal-title":"FASEB J"},{"issue":"1","key":"2025112703415161500_bqaf172-B72","doi-asserted-by":"crossref","first-page":"C3","DOI":"10.1152\/ajpcell.00281.2013","article-title":"Do you know the sex of your cells?","volume":"306","author":"Shah","year":"2014","journal-title":"Am J Physiol Cell Physiol"},{"issue":"9","key":"2025112703415161500_bqaf172-B73","doi-asserted-by":"crossref","first-page":"1427","DOI":"10.1152\/japplphysiol.00303.2012","article-title":"In pursuit of scientific excellence: sex matters","volume":"112","author":"Miller","year":"2012","journal-title":"Journal of Applied Physiology"},{"key":"2025112703415161500_bqaf172-B74","doi-asserted-by":"crossref","first-page":"652444","DOI":"10.3389\/fendo.2021.652444","article-title":"Sex differences in brown adipose tissue function: sex hormones, glucocorticoids, and their crosstalk","volume":"12","author":"Kaikaew","year":"2021","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"1","key":"2025112703415161500_bqaf172-B75","doi-asserted-by":"crossref","first-page":"6072","DOI":"10.1038\/s41467-025-61219-w","article-title":"Sex difference in BAT thermogenesis depends on PGC-1alpha-mediated phospholipid synthesis in mice","volume":"16","author":"Takeuchi","year":"2025","journal-title":"Nat Commun"},{"issue":"2","key":"2025112703415161500_bqaf172-B76","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1038\/s41391-022-00491-z","article-title":"Androgen receptor mutations modulate activation by 11-oxygenated androgens and glucocorticoids","volume":"26","author":"Snaterse","year":"2023","journal-title":"Prostate Cancer Prostatic Dis"},{"issue":"7","key":"2025112703415161500_bqaf172-B77","doi-asserted-by":"crossref","first-page":"e0159867","DOI":"10.1371\/journal.pone.0159867","article-title":"11-Ketotestosterone and 11-Ketodihydrotestosterone in castration resistant prostate cancer: potent androgens which can no longer be ignored","volume":"11","author":"Pretorius","year":"2016","journal-title":"PLoS One"},{"key":"2025112703415161500_bqaf172-B78","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1007\/978-3-319-70178-3_15","article-title":"Estradiol regulation of brown adipose tissue thermogenesis","volume":"1043","author":"Gonzalez-Garcia","year":"2017","journal-title":"Adv Exp Med Biol"},{"issue":"10","key":"2025112703415161500_bqaf172-B79","doi-asserted-by":"crossref","first-page":"3582","DOI":"10.1210\/jc.2016-2311","article-title":"11-Ketotestosterone is a major androgen produced in human gonads","volume":"101","author":"Imamichi","year":"2016","journal-title":"J Clin Endocrinol Metab"},{"key":"2025112703415161500_bqaf172-B80","doi-asserted-by":"crossref","first-page":"105497","DOI":"10.1016\/j.jsbmb.2019.105497","article-title":"The 11beta-hydroxyandrostenedione pathway and C11-oxy C(21) backdoor pathway are active in benign prostatic hyperplasia yielding 11keto-testosterone and 11keto-progesterone","volume":"196","author":"du Toit","year":"2020","journal-title":"J Steroid Biochem Mol Biol"},{"issue":"7","key":"2025112703415161500_bqaf172-B81","doi-asserted-by":"crossref","first-page":"e23574","DOI":"10.1096\/fj.202302131R","article-title":"Inhibition of the glucocorticoid-activating enzyme 11beta-hydroxysteroid dehydrogenase type 1 drives concurrent 11-oxygenated androgen excess","volume":"38","author":"Schiffer","year":"2024","journal-title":"FASEB J"},{"issue":"7","key":"2025112703415161500_bqaf172-B82","doi-asserted-by":"crossref","first-page":"bqac068","DOI":"10.1210\/endocr\/bqac068","article-title":"Conversion of classical and 11-oxygenated androgens by insulin-induced AKR1C3 in a model of human PCOS adipocytes","volume":"163","author":"Paulukinas","year":"2022","journal-title":"Endocrinology"},{"issue":"6","key":"2025112703415161500_bqaf172-B83","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/j.tem.2014.04.001","article-title":"PPARgamma and the global map of adipogenesis and beyond","volume":"25","author":"Lefterova","year":"2014","journal-title":"Trends Endocrinol Metab"},{"issue":"3","key":"2025112703415161500_bqaf172-B84","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1007\/s00018-022-04169-6","article-title":"Regulatory mechanisms of the early phase of white adipocyte differentiation: an overview","volume":"79","author":"Audano","year":"2022","journal-title":"Cell Mol Life Sci"},{"issue":"5","key":"2025112703415161500_bqaf172-B85","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1016\/j.biochi.2009.02.002","article-title":"The role of C\/EBPdelta in the early stages of adipogenesis","volume":"91","author":"Hishida","year":"2009","journal-title":"Biochimie"},{"issue":"2","key":"2025112703415161500_bqaf172-B86","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/j.endonu.2013.03.011","article-title":"Adipose tissue: cell heterogeneity and functional diversity","volume":"61","author":"Esteve Rafols","year":"2014","journal-title":"Endocrinol Nutr"},{"issue":"11","key":"2025112703415161500_bqaf172-B87","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1038\/nrm3198","article-title":"Forming functional fat: a growing understanding of adipocyte differentiation","volume":"12","author":"Cristancho","year":"2011","journal-title":"Nat Rev Mol Cell Biol"},{"issue":"3","key":"2025112703415161500_bqaf172-B88","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.tem.2008.11.005","article-title":"New developments in adipogenesis","volume":"20","author":"Lefterova","year":"2009","journal-title":"Trends Endocrinol Metab"},{"issue":"1","key":"2025112703415161500_bqaf172-B89","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/j.gene.2015.07.037","article-title":"Androgen receptor activation integrates complex transcriptional effects in osteoblasts, involving the growth factors TGF-beta and IGF-I, and transcription factor C\/EBPdelta","volume":"573","author":"McCarthy","year":"2015","journal-title":"Gene"},{"issue":"48","key":"2025112703415161500_bqaf172-B90","doi-asserted-by":"crossref","first-page":"5912","DOI":"10.1038\/onc.2015.41","article-title":"CCAAT\/enhancer binding protein beta controls androgen-deprivation-induced senescence in prostate cancer cells","volume":"34","author":"Barakat","year":"2015","journal-title":"Oncogene"},{"issue":"16","key":"2025112703415161500_bqaf172-B91","doi-asserted-by":"crossref","first-page":"E3334","DOI":"10.1073\/pnas.1616467114","article-title":"Neuroendocrine androgen action is a key extraovarian mediator in the development of polycystic ovary syndrome","volume":"114","author":"Caldwell","year":"2017","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"7","key":"2025112703415161500_bqaf172-B92","doi-asserted-by":"crossref","first-page":"bqaa061","DOI":"10.1210\/endocr\/bqaa061","article-title":"Androgen action in adipose tissue and the brain are key mediators in the development of PCOS traits in a mouse model","volume":"161","author":"Cox","year":"2020","journal-title":"Endocrinology"},{"issue":"1","key":"2025112703415161500_bqaf172-B93","doi-asserted-by":"crossref","first-page":"e3464","DOI":"10.1002\/dmrr.3464","article-title":"Metabolic syndrome and its components in different phenotypes of polycystic ovary syndrome","volume":"38","author":"Krentowska","year":"2022","journal-title":"Diabetes Metab Res Rev"},{"issue":"3","key":"2025112703415161500_bqaf172-B94","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1016\/j.fertnstert.2021.04.018","article-title":"Higher risk of type 2 diabetes in women with hyperandrogenic polycystic ovary syndrome","volume":"116","author":"Persson","year":"2021","journal-title":"Fertil Steril"},{"issue":"3","key":"2025112703415161500_bqaf172-B95","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1016\/j.fertnstert.2016.12.017","article-title":"Normo- and hyperandrogenic women with polycystic ovary syndrome exhibit an adverse metabolic profile through life","volume":"107","author":"Pinola","year":"2017","journal-title":"Fertil Steril"},{"issue":"9","key":"2025112703415161500_bqaf172-B96","doi-asserted-by":"crossref","first-page":"e3414","DOI":"10.1210\/clinem\/dgab380","article-title":"Insulin-mediated substrate use in women with different phenotypes of PCOS: the role of androgens","volume":"106","author":"Tosi","year":"2021","journal-title":"J Clin Endocrinol Metab"},{"issue":"8","key":"2025112703415161500_bqaf172-B97","doi-asserted-by":"crossref","first-page":"2484","DOI":"10.1093\/humrep\/des191","article-title":"Apolipoprotein A-I and B levels, dyslipidemia and metabolic syndrome in south-west Chinese women with PCOS","volume":"27","author":"Zhang","year":"2012","journal-title":"Hum Reprod"}],"container-title":["Endocrinology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/endo\/advance-article-pdf\/doi\/10.1210\/endocr\/bqaf172\/65397658\/bqaf172.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/endo\/article-pdf\/166\/12\/bqaf172\/65397658\/bqaf172.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/endo\/article-pdf\/166\/12\/bqaf172\/65397658\/bqaf172.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,27]],"date-time":"2025-11-27T08:42:11Z","timestamp":1764232931000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/endo\/article\/doi\/10.1210\/endocr\/bqaf172\/8328379"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,6]]},"references-count":97,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2025,11,6]]}},"URL":"https:\/\/doi.org\/10.1210\/endocr\/bqaf172","relation":{},"ISSN":["1945-7170"],"issn-type":[{"value":"1945-7170","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2025,12]]},"published":{"date-parts":[[2025,11,6]]},"article-number":"bqaf172"}}